Moderna raises its revenue outlook — but all eyes are on what happens next with its cancer vaccine

<iframe
  src="https://statesidedaily.com/embed/cluster/aa15ff6cea29c41020fe8489a5a014aedea615d0"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Moderna raises its revenue outlook &#x2014; but all eyes are on what happens next with its cancer vaccine"></iframe>